<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20191221045846N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-06-28</date_registration>
      <primary_sponsor>Rehmatul-Lil-Alameene Post Graduate  Institute of Cardiology</primary_sponsor>
      <public_title>Short term effects of exercises among knee osteoarthritis (OA) participants who are overweight or obese.</public_title>
      <acronym></acronym>
      <scientific_title>Short term effects of strengthening exercises of lower limb rehabilitation protocol (LLRP) on pain, stiffness, physical function and body mass index (BMI) among knee osteoarthritis (OA) participants who are overweight or obese.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-07-10</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>50</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/49143</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The researcher will allocate the selected knee osteoarthritis participants into two groups, namely, Rehabilitation Protocol Group (RPG) and Control Group (CG) by simple random technique using a computer-generated random number. The participants in the RPG will follow the strengthening exercise of LLRP and IDC for duration of 4-weeks. The participants in the CG will not involved in the rehabilitation protocols, but these participants will follow only the IDC for the duration of 4-weeks at their houses, Blinding description: The principle investigator will not be blinded. The participants receiving the intervention will be blinded by simply not informing them of their treatment allocation. The coordinators collecting data will be independent individuals from trials and will be unaware of the group allocation. There will be different coordinators at the initial and final evaluation.  Individuals performing the statistical analysis will be blinded by labelling the groups with non-identifying terms (such as X and Y).</study_design>
      <phase>2</phase>
      <hc_freetext>Osteoarthritis of knee.</hc_freetext>
      <i_freetext>Intervention 1: The participants in this group (Rehabilitation Protocol Group) will perform the strengthening exercises of lower limb rehabilitation protocol (LLRP) and follow the instructions of daily care (IDC) for duration of four weeks at their houses according to the provided leaflet. Each training session of strengthening exercises will be performed three times a week for four weeks at their houses. These training sessions were the strengthening exercises of lower limbs in non-weight bearing sitting and lying positions. Each training session will consist of 45–60 minutes of training followed by 10 minutes warm up at the start and 10 minutes cool down at the end of training protocol. Intervention 2: The participants in this group (Control Group) will follow only the instructions of daily care (IDC) for duration of four weeks at their houses according to the provided leaflet.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Muhammad Tariq Rafiq</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>54000 B.	Rehmatul-Lil-Alamine Post Graduate  Institute of Cardiology, Punjab Employees Social Security Institution, Multan Chongi, Multan Road Lahore</address>
        <city>Lahore</city>
        <country1>Pakistan</country1>
        <zip>54000</zip>
        <telephone>+92 42 99330101</telephone>
        <email>drtariqrafiq149@yahoo.com</email>
        <affiliation>Punjab Employees Social Security Institution</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohamad Shariff A Hamid</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Sports Medicine Department, University of Malaya Medical Centre, Kuala Lumpur, Malaysia</address>
        <city>Kuala Lumpur</city>
        <country1>Malaysia</country1>
        <zip>59100</zip>
        <telephone>+60 3-7967 6669</telephone>
        <email>ayip@um.edu.my</email>
        <affiliation>University of Malaya</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Overweight or obese knee OA participants aged between 45 to 60 years.
Familiar with WhatsApp application
Participants will be chosen from the urban area community of Punjab Lahore, Pakistan.
The sample included males and females having OA of one or both knees confirmed by medical specialist according to the Kellgren and Lawrence radiographic scale for the assessment of OA</inclusion_criteria>
      <agemin>45 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Rheumatoid arthritis
System lupus erythematosus
Flat feet
Spinal deformities
Unable to walk independently
History of metabolic, hormonal, orthopaedic or cardiovascular disease
Previous surgery of knee/s
Injections of knee/s for the last six months.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M17</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Osteoarthritis of knee</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The participants in this group (Rehabilitation Protocol Group) will perform the strengthening exercises of lower limb rehabilitation protocol (LLRP) and follow the instructions of daily care (IDC) for duration of four weeks at their houses according to the provided leaflet. Each training session of strengthening exercises will be performed three times a week for four weeks at their houses. These training sessions were the strengthening exercises of lower limbs in non-weight bearing sitting and lying positions. Each training session will consist of 45–60 minutes of training followed by 10 minutes warm up at the start and 10 minutes cool down at the end of training protocol.</i_keyword>
      <i_keyword>The participants in this group (Control Group) will follow only the instructions of daily care (IDC) for duration of four weeks at their houses according to the provided leaflet.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Knee pain. Timepoint: at baseline and after 4 weeks of intervention. Method of measurement: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score.</prim_outcome>
      <prim_outcome>Stiffness. Timepoint: At baseline and after 4 weeks of intervention. Method of measurement: WOMAC score.</prim_outcome>
      <prim_outcome>Physical function. Timepoint: At baseline and after 4 weeks of intervention. Method of measurement: WOMAC score.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Body Mass Index. Timepoint: At baseline and after 4 weeks of intervention. Method of measurement: Calculated by the formula Weight (kg)/Height(meter square).</sec_outcome>
      <sec_outcome>Patients satisfaction. Timepoint: After 4 weeks of intervention. Method of measurement: Numeric rating scale ranging from 0 to 10.</sec_outcome>
      <sec_outcome>Exercise adherence. Timepoint: After 4 weeks of intervention. Method of measurement: Numeric rating scale ranging from 0 to 10.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name>University of Malaya</sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Rehmatul-Lil-Alameene Post Graduate  Institute of Cardiology</source_name>
      <source_name>N/A</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-05-20</approval_date>
        <contact_name>Ethical Committee RAIC PESSI (Rehmatul-Lil-Alameen Postgraduate Institute of Cardiology, Punjab Empl</contact_name>
        <contact_address>Multan Chongi Multan Road Lahore, Lahore Punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
